Fatouros IG, Douroudos I, Panagoutsos S et al Effects of L-carnitine on oxidative stress responses in patients with renal disease
Caruso S, Cicero C, Romano M, Lo Presti L, Ventura B, Malandrino C
The study assessed drug utilization and temporal changes in treatment options (e.g., SGLT2i, GLP-1 RA) in adults with CKD and type 2 diabetes regarding two time periods: an earlier period (1 January 201230 June 2021) and a later period after the US approval of finerenone (9 July 202130 September 2023), with the latter period representing updated treatment guidelines, changes to CKD drug labeling (e.g., SGLT2i), and the availability of new CKD-protective medications (ESM Fig
CHILL: Place food immediately in the refrigerator or freezer after use
Notably, the small molecule necrostatin-1 serves as a molecular tool for precisely modulating necrotic apoptosis subtypes by blocking RIPK1-dependent necroptosis through the ATP-binding pocket of the RIPK1 kinase domain